| abstract |
There is described a compound of the general formula (I) or pharmaceutically acceptable prodrugs, salts, hydrates, solvates, crystal forms, and isomeric forms thereof, a pharmaceutical composition comprising a compound of general formula (I), a method for the treatment of a tyrosine kinase-associated disease state and a method of suppressing the immune system using a compound of general formula (I). |